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ABSTRACT In this article we extend the Iterative Protein Redesign and Optimization (IPRO) framework for the design of
protein libraries with targeted ligand speciﬁcity. Mutations that minimize the binding energy with the desired ligand are identiﬁed.
At the same time explicit constraints are introduced that maintain the binding energy for all decoy ligands above a threshold
necessary for successful binding. The proposed framework is demonstrated by computationally altering the effector binding
speciﬁcity of the bacterial transcriptional regulatory protein AraC, belonging to the AraC/XylS family of transcriptional regulators
for different unnatural ligands. The obtained results demonstrate the importance of systematically suppressing the binding
energy for competing ligands. Pinpointing a small set of mutations within the binding pocket greatly improves the difference in
binding energies between targeted and decoy ligands, even when they are very similar.
INTRODUCTION AND OBJECTIVES
Asweenter the postgenomic erawehave in ourhandsa plethora
of protein designs, experimental techniques, and computational
methods. Recent developments (1–3) have made it clear that
given sufﬁcient resources and screening capabilities, directed
evolution can be used to drastically improve protein function. A
variety of protocols are available for performing targeted
mutagenesis or constructing combinatorial libraries with cus-
tomized statistics of mutations and/or parental fragments (see
Moore and Maranas (4) for a review), raising the question of
what typeofmutations and/or recombination events are likely to
yield functionally enriched protein libraries. This underlines the
task of constructing protein libraries enriched with desired
functions compared to a random sampling of protein sequence
space. The challenge here is in effectively searching sequence
space to ﬁnd improved variants containingmultiplemutations
and particularly to identify interacting mutations whose
effects on ﬁtness are nonadditive.
Computer simulations play an increasingly signiﬁcant role
in understanding the underlying physical principles that dictate
protein folding, stability, and function, leading to greatly
improved protein design predictions (4). Although it is not yet
feasible to consistently predict structure and function de novo,
it is possible to assess the impact ofmutations on existing,well-
characterized proteins (5–8). The goal of this study is tomodify
the Iterative Protein Redesign and Optimization (IPRO)
computational protein library design framework (1) to enable
the systematic redesign of proteins for desired ligand speciﬁc-
itywhile suppressing the afﬁnity toward competingmolecules.
The approach is demonstrated through a comprehensive com-
putational study involving the redesign of the L-arabinose-
responsive bacterial transcriptional regulatory protein AraC to
accept targeted unnatural ligands as transcriptional activating
‘‘effector’’ molecules (9). This is an important endeavor be-
cause the precise control of gene transcription in response to
speciﬁc stimuli has wide implications ranging from synthetic
biology and metabolic engineering to the development of
customized genetic selections for use in subsequent protein
engineering projects. Furthermore, the regulatory properties of
AraCmake it a good candidate for protein engineering because
of the natural coupling of molecular recognition to gene
transcription, enabling the use of a genetic selection and/or
high-throughput screening procedure to rapidly identify mu-
tantswith improvedbinding speciﬁcity. Finally, the availability
of high-resolution atomic-level x-ray crystal structures of the
effector-binding/dimerization domain of AraC in the presence
and absence of L-arabinose (10) allows for computationally
modeling novel effector recognition.
We describe the use of simulation and optimizationmethods
to accurately reﬂect the relative strengths with which wild-type
AraC binds various compounds. IPRO is subsequently used to
predict mutagenesis strategies resulting in altered binding
selectivity. Speciﬁcally, we explore the design of AraC variants
responding to novel effector molecules that increasingly
resemble L-arabinose (e.g., cis-verbenol, followed by D-arabi-
nose). Our interest in binding target molecules such as cis-
verbenol stems from a need to develop biocatalysts capable of
converting renewable and abundant natural resources (including
plant oils such as those containing a-pinene) into value-added
products such as antibiotics, pharmaceutical intermediates, and
chemicals for the ﬂavor and fragrance industry.
AraC SYSTEM
The AraC monomer is a 292–amino acid polypeptide
composed of an N-terminal effector binding/dimerization
domain (residues 1–170) followed by a C-terminal DNA-
binding domain. Under physiological conditions, the AraC
protein exists primarily as a dimer that tightly regulates
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transcription from the PBAD promoter by acting as a repressor
in the absence of inducer (by forming a DNA loop in the
promoter region) and as an activator in response to inducer
(L-arabinose) (10,11). The L-arabinose binding ‘‘signal’’ is a
conformational change in the AraC dimer that consequently
disrupts the DNA loop and activates transcription. This signal
is transmitted from the N-terminus to the DNA binding
domain via movement of the N-terminal arm. In the absence
of the inducer, this arm is believed to make contacts with the
C-terminal domain (12), whereas in the presence of
L-arabinose, this armcloses over theN-terminal bindingpocket.
Induction of the ara operon is speciﬁc to L-arabinose:
Structurally and chemically similar sugars such D-xylose
and D-arabinose fail to act as wild-type AraC effectors (13).
D-Fucose,which is identical to L-arabinose at all positions except
C5 (where fucose contains a methyl group instead of a hy-
drogen), acts as a competitive inhibitor that binds AraC (in the
same position as L-arabinose) but fails to induce gene expression
in vivo or in vitro (13,14). AraC mutants have been isolated
that are induced by fucose (13,15). Thus, as in the case of other
receptors (16,17), very similar small molecules can have dras-
tically different binding afﬁnities and stimulatory effects.
COMPUTATIONAL PROCEDURE
Modiﬁcation of IPRO framework
Weuse binding calculations to score the relative strengths with
which AraC binds various compounds and subsequently
deploy mathematical optimization to suggest mutagenesis
strategies resulting in the desired altered binding selectivity.
Binding energy, which is computationally approximated using
the CHARMM (18,19) energy function, accessed through the
IPRO optimization framework, serves as a surrogate of
molecular recognition (i.e., binding afﬁnity) (1). The optimi-
zation step identiﬁes mutations that lead to stronger binding
scores for the desired ligand while at the same time depressing
binding scores for competing molecules.
Theprotein redesign framework IPROprovides the backbone
of the computational environment for the redesign of AraC
binding speciﬁcity (1). Brieﬂy, it involves iterative optimal
protein redesign of residues/rotamers (near the binding pocket)
followed by backbone relaxation and ligand(s) redocking.
Speciﬁcally, during each iteration a local backbone perturbation
window (i.e., one to ﬁve residues) is randomly selected, and a
perturbation of the backbone is imposed. New residues (i.e.,
mutations) and corresponding rotamers are identiﬁed by
globally optimizing the binding score within the redesign
window and readjusting rotamers within a wider window (11–
15 residues) around the regionof perturbation.This optimization
step is followed by backbone relaxation and ligand(s) redocking
(20). If the redesign and corresponding structural modiﬁcations
lead to an improved binding score, then the perturbation is
accepted. If the redesign leads to aworse binding score, then it is
accepted or rejected based on theMetropolis criterion (21). This
iterative cycle forms the basic working paradigm of IPRO.
Improving binding afﬁnity of a regulatory protein must also
take into account the competitive nature of the process. Spe-
ciﬁcally, at the same time that binding afﬁnity for the targeted
ligand is improved, the afﬁnity for competing molecules must
be depressed. This new design paradigm warrants a number
of modiﬁcations in the general IPRO procedure. We address
this challenge in this article by putting forth and solving a
two-level optimization problem. In the outer level, new designs
(i.e., residue choices) aremade,while in the inner level separate
rotamer sets are identiﬁed that optimize the binding with
respect to the desired and undesired substrates. A constraint
ensures that the binding score for even the best conformation
(i.e., rotamer choices) for the undesirable ligand(s) remains
greater than what is needed for successful binding of the
desired ligand. When this threshold is exceeded, the corre-
sponding design choice is deemed infeasible. The structure of























The inner minimization problems identify separate rotamer
combinations that minimize the binding energyEwith respect
to the desired L1 and competing (L2, L3, . . . , Ln) ligands.
For all competing ligands this minimum binding energy is
FIGURE 1 Two-level optimization formulation of the modiﬁed IPRO. In
the outer level new designs with respect to amino acids choices are gen-
erated, whereas the inner level identiﬁes the rotamer choices that minimize
the binding energy with respect to various ligands. By changing rotamers,
the amino acids are chosen such that the binding energy with respect to all
undesired ligands is above a cutoff value, preventing their binding while
simultaneously ensuring sufﬁciently low binding energy with respect to the
targeted ligand to enable binding.
Protein Redesign for Ligand Speciﬁcity 2121
Biophysical Journal 92(6) 2120–2130
constrained to be above a high enough thresholdM preventing
effective binding (see Fig. 1). We use known good/poor
binders for a given protein system to arrive at appropriate
values for M. Note that the inner part of the optimization
problem is decomposable into n separable minimization
problems that can be run on separate processors. Similar to the
original IPRO procedure, the outer optimization problem is
solved using the Metropolis criterion to update amino acid
choices after each iteration. Backbone relaxation and ligand-
redocking steps can also be used after each time the inner
rotamer optimization problems are solved. Fig. 2 pictorially
illustrates the computations workﬂow of the modiﬁed IPRO
framework.
COMPUTATIONAL PREDICTIONS
A key consideration for any successful AraC redesign is to
retain the ‘‘light-switch’’ mechanism of the ara regulatory
operon (22) that preserves the coupling between binding and
transcriptional activation. Extensive mutagenesis analyses by
Schleif and colleagues have identiﬁed a series of ‘‘hemiple-
gic’’ AraC mutations that speciﬁcally block either induction
(I-) or repression (R-) at PBAD (22,23). Many other mutations
in the N-terminal arm are reported to cause constitutivity
or uninducibility (23). In our studies it is important for the
N-terminal arm in engineered AraC variants to maintain
contact with the C-terminal domain in the absence of inducer
and to disfavor contact in the presence of an inducer (favoring
instead arm-inducer interactions). Based on these require-
ments, we have computationally disallowed critical residue
positions from being mutated. Sixteen residues of the 32
residues forming the binding pocket were selected as design
positions. Mutations at these selected positions (located in the
N-terminal domain) are presumed to weaken L-arabinose
binding interactions while preserving the repression of the
ara regulatory operon in the absence of the effector (22,23).
Therefore, these positions were deemed to be viable candi-
dates to be considered as design positions to confer novel
speciﬁcity in AraC protein.
The structure of AraC complexed with L-arabinose shows
an extensive network of water molecules within the ligand-
binding pocket (10). This network of water molecules
mediates hydrogen bonds between the ligand and AraC,
thus affecting the binding and location of the ligand in the
pocket. We computationally explored the effect of placing
16 structural water molecules in the binding pocket in the
docking calculations. It has been acknowledged (24–26) that
water-mediated interactions can affect the stability, dynamics,
and the placement of the protein backbone. We ﬁnd that add-
ing water molecules improves protein docking and thus results
in more accurate ligand positioning. Predicted ligand posi-
tions for L-arabinose and D-fucose more closely match the
known crystal structures (calculated RMSD ¼ 0.20 A˚ for the
two sugars) when water molecules are included in the calcu-
lations compared to the predicted positions in the absence of
water (RMSD¼ 3.53 A˚). Therefore, in the following detailed
FIGURE 2 (A) Local region of the
protein (1–5 consecutive residues
around the targeted ligand) is randomly
chosen for perturbation. The u and c
angles of the targeted position (as
shown in the circle) are perturbed by
up to 5. (B) All amino acid rotamers
consistent with these torsion angles
are selected at each position from the
Dunbrack and Cohen rotamer library
(35,36). Rotamer-backbone and rota-
mer-rotamer energies are calculated
for all the selected rotamers. (C) The
binding energy is minimized using a
MILP formulation to select the optimal
rotamer at each of these positions. (D)
After rotamer selection for the target
molecule, the nontarget ligand is docked,
and its binding energy is calculated
using the CHARMM energy function
(18,19). The best conformation (i.e.,
rotamer choices) is accepted if it en-
sures that the binding score for the
undesirable ligand(s) remains greater
than what is needed for successful
binding. When this threshold is ex-
ceeded, the corresponding design choice is deemed infeasible. (E) In this step the backbone and the targeted ligand are allowed to relax to adjust to the changes
in the side chains. This is achieved by allowing u and c to vary freely and to be determined during energy minimization. (F) ZDOCK software is employed to
readjust the targeted ligand position regarding the modiﬁed backbone and side chains (20). (G) Protein-ligand binding energy is computed using CHARMM
energy functions. If the binding energy for the target ligand is lower than the previous best ligand structure then this move is accepted as best solution
otherwise, (H) Metropolis criterion is used to decide whether to accept or reject the move.
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studies we report on results in the presence of structural water
molecules.
The validity of using computationally derived binding
energy as surrogate for molecular recognition was ﬁrst tested
by calculating binding energies for different sugars (i.e.,
L-arabinose, D-fucose, D-arabinose, L-lyxose, D-lyxose, L-xylose,
D-xylose, L-ribose, and D-ribose) using the CHARMM
(18,19) energy function. The calculated values were subse-
quently contrasted against experimental data available in the
literature (13,23,27–30). We ﬁnd that the calculated binding
energies qualitatively reﬂect the experimentally observed
absence of transcriptional activation for the tested sugars
(Fig. 3). Speciﬁcally, L-arabinose and D-fucose, two sugars
known to bind to theAraCprotein, have the twomost negative
binding energy scores. Several of the tested sugars including
L,D-xylose and L-lyxose were also veriﬁed by Doyle et al.
to not inhibit induction by L-arabinose, implying that these
sugars are certainly not bound by AraC (13). These results
bolster the assumption that binding energy is a reasonable
surrogate for ligand binding by AraC, which is at least a
requirement for transcriptional activation. Further experi-
mental analysis is necessary to determine whether (or how
readily) binding energy correlates with a ligand’s ability to
induce transcription.
Four case studies are addressed here to demonstrate the
proposed computational procedure. The ﬁrst study involves
engineering AraC variants that bind cis-verbenol, one of the
oxidized forms of the bicyclic monoterpenea-pinene without
proactively depressing afﬁnity for competitive ligands. This
study explores the ability of modiﬁed IPRO to redesign a
transcription factor (i.e., AraC) to recognize an effector
molecule very different in structure and chemistry from
L-arabinose (Fig. 4). In the second study, we redesign AraC to
recognize cis-verbenol but at the same time not bind its
reduced form a-pinene. In the third case study, we again
redesign AraC to selectively bind cis-verbenol but at the same
time not bind verbenone, an alternative oxidized product of
a-pinene that is chemically and structurally very similar to
cis-verbenol. Finally, in the fourth case study we computa-
tionally redesign AraC protein to impart novel effector
selectivity capable of distinguishing between different chiral
forms of the arabinose sugars (i.e., L- and D-arabinose). The
binding energy values for known poor binders for the AraC
proteinwere used to choose appropriate binding energy cutoff
values. For the second case study, this cutoff value was set at
20.0 kcal/mol. This value is higher than the binding energies
of D-xylose (Fig. 3), which is known not to bind AraC.
Furthermore, for the third and fourth case–studies, a tighter
cutoff value of 30 kcal/mol was chosen to help elucidate
mutations that sharpen speciﬁcity toward the target ligand
from very similar competing ligands. In these four studies,
several computational libraries were constructed using dif-
ferent sets of randomization seeds for the iterative backbone
perturbation employed by IPROduring each design cycle.We
found that in all cases although the amino acid design choices
can vary between different randomization runs, the underly-
ing properties of the selected amino acids are preserved. The
modiﬁed IPRO procedure is run for all studies on a Linux PC
cluster with 3.06-GHz Xeon CPU/4GB RAM, for a total of
4000 major iterations.
Binding of cis-verbenol
We have veriﬁed that neither a-pinene nor its oxidized forms
cis-verbenol and verbenone induce transcription from the ara
regulatory operon (H. Fazelinia, P. Cirino, andC.D.Maranas,
The Pennsylvania State University, unpublished data). Mean-
while their calculated binding energies using CHARMM-
based energy functions are signiﬁcantly higher than those
calculated for native inducers, indicating that these com-
pounds are not bound by AraC.
In the ﬁrst case study, we address the engineering of AraC
to bind cis-verbenol without considering the effect of the
identiﬁed mutations on the binding of other competitive
ligands. Computational results for redesigning the effector-
binding site of AraC for cis-verbenol have revealed a number
FIGURE 3 Binding energies of the various sugars with
AraC protein. L-Arabinose and D-fucose, known to bind to
AraC, have the most negative binding energies.
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of important redesign trends. Of 16 design positions (i.e.,
positions allowed tomutate), positionsAsp7, Phe35, Asn48, and
His80 are always conserved as wild-type. Several mutations
within the binding pocket are found that can signiﬁcantly alter
the calculated binding speciﬁcities of the receptor (seeTable 1).
Predicted mutations in positions Phe15, Phe34, Ile36, Arg38,
Tyr82, and Trp91 are found to signiﬁcantly lower the volume of
the binding site, consistentwith the fact that the new ligand (i.e.,
cis-verbenol) is 45% larger than L-arabinose (see Fig. 5). Also,
hydrophilic amino acids tend to replace Ala17, Val20, and
Leu23, which are located in a solvent-exposed area ofAraC and
do not directly affect the binding of the ligand.
Similar to the position of L-arabinose bound to AraC, cis-
verbenol is predicted to stack against the indole ring of Trp95
(see Fig. 6). Ligand binding is stabilized by hydrogen bonds
and van der Waals (vdw) interactions between side chains of
residues within the binding pocket and the hydroxyl and
aliphatic groups of cis-verbenol, respectively. TheN-terminal
arm of AraC is predicted to form both direct and indirect
contacts with the verbenol, resulting in complete burial of the
new ligand. The hydrogen bond between the OH group of cis-
verbenol and the main-chain carbonyl of Pro8 and vdw
interactions between the cis-verbenol C5 and C7 methyl
groups and the side chain of amino acids in positions 13 and
15 stabilize the position of the N-terminal arm. Although
His93 plays an important role in binding L-arabinose, this
residue is not involved in cis-verbenol binding. In contrast,
amino acids in positions 36 and 42, not involved in binding
and recognition of L-arabinose, are predicted to play signif-
icant roles in binding cis-verbenol. Hydrophilic amino acids
predicted to replace Ile36 create a new hydrogen bondwith the
OH group of the new ligand and are in vdw contact with its C3
methyl group (see Fig. 6). Furthermore, wild-type Met42 is
predicted to be in vdw contact with the C10 methyl group of
cis-verbenol. The replacement of Thr24 (involved in binding
L-arabinose) with larger amino acids such asGln stabilizes the
position of the new ligand in the binding pocket by creating a
new hydrogen bond with the OH group of cis-verbenol.
Overall, computational results (see Table 1) indicate that
despite the structural and chemical difference between cis-
verbenol and L-arabinose, IPRO does identify sets of muta-
tions typically involving ;12 mutated positions within the
binding site that lower the binding energy from 16.82 kcal/
mol to as low as 55.54 kcal/mol.
Binding of cis-verbenol but not a-pinene
Although the redesigns described above managed to lower
the binding score substantially for cis-verbenol, this does
not necessarily sharpen ligand speciﬁcity. Speciﬁcally, the
binding energy of the redesignedAraCwitha-pinene not only
remains negative but also increases in absolute value (i.e.,
changes from 12.58 to 46.54 kcal/mole). This quantita-
tively demonstrates that when the binding energy for a new
FIGURE 4 Structures of the targeted
and decoy molecules in the four case
studies.
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ligand is optimized with no regard to the binding energy for
the competitive ligand(s), it typically leads to a redesign that
appears to have broader speciﬁcity (31–33). This result
motivates the need to proactively suppress the binding energy
for a-pinene while optimizing the binding energy for cis-
verbenol. We use the modiﬁed IPRO procedure (as described
above) to accomplish this objective. With the modiﬁed
version of IPRO, the binding energy of cis-verbenol is
FIGURE 5 Size and hydrophobicity
distribution of the wild-type amino acids
(blue column), designs for case study 1
(red column), case study 2 (yellow col-
umn), and case study3 (green column) for
all design positions.










but not a-pinene (case study 2)
Binding of cis-verbenol
but not verbenone (case study 3)
7 Asp WT* WT WT
15 Phe Gly, Gln, His Gly, His, Thr Gly, Gln, His
17 Ala Gln, Arg Asn, Arg Gln, Arg
20 Val Arg, Thr, His Trp, Gln Tyr, Arg, Thr
23 Leu Gln, Glu, Lys Trp, Gln, Lys Phe, Gln, Glu, Lys
24 Thr Val, Asn, Gln WT His, Gln, Glu
32 Leu Tyr, Asn, Arg Gln, His, Phe Ala, Ser, Tyr, Asn, Arg
34 Phe Met, Glu, His Tyr, Gln, Arg, His Arg, Glu, Gln, His
35 Phe WT WT WT
36 Ile Thr, Asn Asn Asn, Asp
37 Asp Val, Lys, Arg Lys, Arg Val, Lys, Arg
38 Arg Ala, His, Trp Ala, His His, Ala, Trp
48 Asn WT WT WT
80 His WT WT WT
82 Tyr Ala, Phe WT Gly, Ala, Phe
91 Trp Gly, Ala, His Phe, Arg, His Ala, Gly, His
*WT refers to wild-type AraC.
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lowered from 16.82 kcal/mol to –50.19 kcal/mol while at
the same time the binding energy of the redesigned AraCwith
a-pinene remains approximately the same (i.e., changes only
from12.58 kcal/mol to10.03 kcal/mol). In addition to the
same four positions that remain unmutated in the previous
case (i.e., 7, 35, 48, and 80), residues Thr24 and Tyr82 are also
conserved. The overall mutated amino acid size patterns
between the two computed libraries are very similar (see
Table 1 and Fig. 5), except for positions 15 and 91, where in
the second case study predicted residues are more than 20%
different in size. Smaller amino acids are preferred in the
second library compared with the solutions found in the ﬁrst
library at position 15, whereas larger ones are favored at
position 91. Having a smaller amino acid at position 15
reduces the magnitude of a vdw interaction implicated in the
binding of a-pinene. The role of larger residues at position 91
is less clear. The hydrophobicity patterns of the mutated
residues in the two libraries are also very similar. Only subtle
differences can be discerned at positions 15 and 38, which are
presumably implicated in the destruction of the hydrophobic
interactions needed for the binding of a-pinene with AraC.
Consistent with the previous case study, more hydrophilic
amino acids are favored to replace the wild-type amino acids
at positions Val20 and Leu23, which are located in the solvent-
exposed area. Fig. 7 contrasts in aVenn diagram themutations
found in the two case studies along with the quantitative
impact of each single-point mutation on the binding energy
for the two ligands. We see that some mutations, when their
impact on a-pinene binding is ignored, tend to improve both
binding scores, whereas others only improve the binding
score with cis-verbenol alone. Mutations found on system-
atically suppressing the binding score with a-pinene consis-
tently favor binding only cis-verbenol. Among thesemutations
there is a subset common to both case studies. Notably, in both
cases there seems to be a strong additive component in the
action of the mutations. If the mutations in all three regions
shown in Fig. 7 are combined, the binding score changes are
almost additively ampliﬁed.
Binding of cis-verbenol but not verbenone
Next we attempt to redesign AraC computationally to dis-
criminate between different oxidized forms of the bicyclic
monoterpene a-pinene (i.e., cis-verbenol and verbenone; see
Fig. 4). These two molecules are identical at all positions
except C4, where hydroxyl oxygen and carbonyl oxygen are
present for cis-verbenol and verbenone, respectively. There-
fore, the computational redesign simulation must identify
suitable amino acid choices for the binding pocket residues
based only on this small difference. Comparison between the
computed libraries for this case study and the ﬁrst one, where
only cis-verbenol was considered as the target ligand, reveals,
as expected, only subtle differences in size, hydrophobicity,
and charge (see also Table 1 and Fig. 5). Notably, at positions
24 and 36, more hydrophilic amino acids are favored.
In verbenone the carbonyl oxygen acts only as a hydrogen-
bond acceptor, whereas the hydroxyl oxygen in cis-verbenol
is a hydrogen donor and also an acceptor. Different amino
acids are selected to form hydrogen bonds with the two
ligands. To discern what amino acids favor the binding of
verbenone, results from the predicted library in the ﬁrst case
study are contrasted against results from the library in which
only verbenone was considered as the target molecule. We
ﬁnd that wild-type Thr24 and Lys36 are favored, acting as hy-
drogen bond donors to interact with the nonbonding electron
FIGURE 6 Best predicted orientation of cis-verbenol (shown with its
vdw surface area) in the redesigned binding pocket of AraC from two dif-
ferent angles. Hydrogen bonds are shown with green lines; cis-verbenol is
predicted to stack against the indole ring of Trp95 and networks of hydrogen
bonds, and vdw interactions are responsible for placing the ligand in the
binding pocket.
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pairs in the carbonyl oxygen in verbenone. On the other hand,
computed libraries in the third case study favor His, Gln, and
Glu for position 24 and acidic amino acids Asn and Asp for
position 36. These mutations allow the unprotonated imida-
zole nitrogen of histidine and carbonyl oxygen of the acidic
amino acids to form hydrogen bonds with the hydroxyl group
of cis-verbenol and thereby stabilize the position of the target
molecule in the pocket.
Overall, in this case study, binding energy of cis-verbenol
improves from16.82 kcal/mol to –51.23 kcal/mol, while at
the same time the binding energy of the redesignedAraCwith
verbenone also decreases from 15.85 kcal/mol to 34.03
kcal/mol. The inability to further suppress binding with
verbenone compared with the second case study is presum-
ably a consequence of the fact that the competing molecule
here is extremely similar to the targeted ligand (see Fig. 8).
FIGURE 7 AraC protein (PDB:
2ARC) was redesigned using IPRO to
bind cis-verbenol without any regard to
the corresponding binding score of com-
petitive ligands (mutations are shown
within the dark gray circle). The mod-
iﬁed version of IPRO was also em-
ployed to proactively suppress the
binding energy for a-pinene while
optimizing the binding energy for cis-
verbenol (mutations are shown within
the white circle). Common mutations
between the two are placed in the
overlapping regions between circles.
FIGURE 8 AraC protein (PDB:
2ARC) was redesigned using IPRO to
bind cis-verbenol without any regard to
the corresponding binding score of com-
petitive ligands (mutations are shown
within the dark gray circle). The mod-
iﬁed version of IPRO was also em-
ployed to proactively suppress the
binding energy for verbenone while
optimizing the binding energy for cis-
verbenol (mutations are shown within
the white circle). Common mutations
between the two are placed in the
overlapping regions between circles.
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Speciﬁcity alteration from L- to D-arabinose
It has been shown that, in contrast to the stimulatory effect of
L-arabinose, its enantiomer D-arabinose is unable to activate
transcription in the ara regulatory operon (34). Here we
address the computational redesign of AraC to enhance the
binding score for D-arabinose as opposed to L-arabinose. This
corresponds to a challenging task given that both enantiomers
have exactly the same molecular groups. Therefore, the
computational redesign procedure must identify appropriate
residue choices for the active site based on only the differing
stereogeometries between the two enantiomers. As before,
ﬁrst we identiﬁed mutations that improve the binding score of
D-arabinose without any regard to the corresponding binding
score for L-arabinose. We next accumulated (see Table 2) all
the AraC redesigns that improve the D-arabinose binding
score and disfavor the L-arabinose at the same time. The role
of the identiﬁed mutations is more clearly elucidated by
considering the underlying impact of these mutations on the
volume, hydrophobicity, and charge at each position. Nota-
bly, the predicted mutations are few and involve only subtle
changes in the size and hydrophobicity of the AraC binding
pocket. Of 16 positions considered for redesign, we found that
10 positions are mutated away from wild-type (Table 2). As
expected, because L-arabinose and its enantiomer D-arabinose
have exactly the same size, we found that the average volumes
at each position remain very close to those of the wild-type
residues. The same holds, to a lesser extent, for the average
hydrophobicity of the redesigned AraC pocket. For 11 design
positions, the average hydrophobicity of residues in the
redesigned AraC is very similar to the wild-type residues,
although the hydrophobic characteristics of amino acids
predicted to replace positions 20, 23, 36, 37, and 48 differ
from the wild-type residues (Table 2).
Interestingly, despite the difference in topology between
L- and D-arabinose, the sugar is stabilized similarly in the
wild-type and all redesigned AraC variants (10). Speciﬁcally,
in the redesigned AraC, Arg38 forms a bidentate interaction
with two of the hydroxyl groups of the bound sugar, resem-
bling the interactions that exist between Arg38 and L-arabinose
in wild-type AraC. Meanwhile, as in the wild-type AraC, all
predicted structures have D-arabinose stacking against the
indole ring of Trp95, and the ligand position is stabilized by a
network of hydrogen bonds between D-arabinose and binding
pocket residue side chains (see Fig. 9).
In all computed redesigns of AraC in this case study, the
position of the N-terminal arm is stabilized by a hydrogen
bond between the main chain carbonyl of Pro8 and one of the
hydroxyl groups of the bound sugar (see Fig. 9). This
interaction is very similar to that found in wild-type AraC,
where the anomeric hydroxyl group (OH-1) of the bound
sugar interacts with the main chain carbonyl of Pro8 (10). It is
important to note that no speciﬁc information about the
TABLE 2 Identiﬁed mutations for improving the binding of








Binding of D- but
not L-arabinose
7 Asp WT* WT
15 Phe WT WT
17 Ala Gly,Tyr, Arg Gly, Tyr, Arg
20 Val Gln, Glu, Arg Thr, Gln, Arg
23 Leu Met,Trp, Lys, Ile Lys, Glu, Gln
24 Thr Asn, Gly, Ala Ala
32 Leu Tyr, Phe, His Ala, Gly, Phe, His
34 Phe Met, Arg, Glu His, Met, Glu
35 Phe Gln, Tyr Glu, Tyr
36 Ile WT WT
37 Asp WT WT
38 Arg WT WT
48 Asn Lys, Gln, Ala, Ile Gln, Ala
80 His Gln, Asp, Ala Gln, Phe, Asn
82 Tyr Thr, Ala, Met Phe, Glu, His
91 Trp WT His, Phe, Met
*WT refers to wild-type AraC.
FIGURE 9 Location of L-arabinose (a) and D-fucose (b) in the binding
pocket of the AraC (PDBs:2ARC, 2AAC). Model-predicted positions of
D-arabinose in the presence (c) and in the absence (d) of water-mediated
interactions. IPRO-predicted ligand positions more closely match those
found from the crystal structures when water is included. Computational
results indicate that in both cases the position of the N-terminal arm of AraC
is stabilized by the main chain carbonyl of Pro8, which makes a hydrogen
bond with one of the hydroxyl groups of sugars. In both cases, the sugar
stacks against the indole ring of Trp95.
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stabilizing interactions was a priori provided to the IPRO
model. As in the previous case studies, the redesign of AraC
substantially improves the binding energy for D-arabinose
(from 15.43 kcal/mol to 107.41 kcal/mol), but the binding
score for L-arabinose is also lowered (from 37.21 kcal/mol
to 78.35 kcal/mol).
In the modiﬁed version of IPRO, mutation changes that
suppress binding with L-arabinose were next identiﬁed (see
Table 2). In 12 of 16 design positions, the mutations are very
similar to the ones foundwhen the binding score of D-arabinose
was minimized. The binding score with D-arabinose is lowered
from 15.43 kcal/mol to –89.698 kcal/mol, whereas the binding
score for L-arabinose increases in this scenario from 37.21
kcal/mol to18.03 kcal/mol. Comparisons between computed
libraries for these two cases reveal only subtle differences in
charge, hydrophobicity, and size distributions. One such
difference is the replacement of Thr24 with aliphatic residues,
partly destroying the hydrogen bond network involved in
binding L-arabinose and thus diminishing the afﬁnity of AraC
for its natural effector. In contrast, mutating His80 to hydro-
philic residues (Gln, Ser, Asn) creates a new hydrogen bond
with D-arabinose (but not L-arabinose). The binding scores for
individual mutations were calculated and are presented in Fig.
10 in the form of a Venn diagram for both cases.
DISCUSSION
In this article, we introduced a modiﬁed version of the IPRO
protein design framework to enable the systematic redesign of
proteins for improved binding afﬁnity for a targeted ligand
while the binding afﬁnity for decoy ligands remains low.
Computationally, this leads to a nested optimization structure
where, in the inner stage, the rotamer optimization problem is
solved separately for all ligands, whereas in the outer stage,
residue redesign choices aremade (see Fig. 1). This procedure
was benchmarked using AraC as a model system by favoring
the binding of targeted ligands (i.e., cis-verbenol or D-arabinose)
while suppressing the binding energy of competingmolecules
(i.e., verbenone, a-pinene, and L-arabinose).
We found that failure to suppress the binding afﬁnity for
competing ligands leads to a universal improvement in the
binding scores not only for the targeted but also for the decoy
ligands. The modiﬁed IPRO procedure was shown to be
capable of decoupling the two and identifying mutations
that improve the binding only with the desired ligand. As
expected, this decoupling was most difﬁcult to achieve for
very similar molecules (i.e., cis-verbenol and verbenone),
which differ by only one group. Somewhat surprisingly,
this decoupling was much easier for enantiomers (i.e., L- and
D-arabinose), suggesting that proteins can be more readily
modiﬁed to discern differences in ligand topology rather than
ligand small group substitutions.
In all four case studies the ligand was stacked against the
indole ring of Trp95, and networks of hydrogen bonds and
vdw interactions were responsible for placing the respective
ligand in the binding pocket. The position of the N-terminal
arm, which plays a crucial role in the ‘‘light-switch’’ mech-
anism of the AraC protein, was universally stabilized by
direct hydrogen bonding between the oxygen of the main
chain carbonyl of Pro8 and one hydroxyl group of the target
ligand. The average volume of the amino acids in the binding
pocket was generally changed according to the size of the
target ligand to improve the ligand-protein ﬁt by compen-
sating for differences in ligand structure.
FIGURE 10 AraC protein (PDB:
2ARC) was redesigned using IPRO
to bind D-arabinose without any regard
to the corresponding binding score
for L-arabinose (mutations are shown
within the dark gray circle). The mod-
iﬁed version of IPRO was also em-
ployed to proactively suppress the
binding energy for L-arabinose while
optimizing the binding energy for
D-arabinose (mutations are shown
within the white circle). Common mu-
tation positions are placed in the over-
lapping region between the two circles.
Protein Redesign for Ligand Speciﬁcity 2129
Biophysical Journal 92(6) 2120–2130
Comparisons between the different computed libraries
reveal that, in all case studies, all mutations found on sys-
tematically suppressing the binding score with the decoy
consistently favor binding with only the target ligand. The
number of common mutations predicted with and without a
decoy strongly depends on the similarity of the chemistry and
structure between the target and decoy molecules. Finally,
in all cases, improvements in the binding scores are largely
cumulative with respect to individual point mutations, allud-
ing to a strongly additivemechanismof the effect ofmutations.
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